Strategic Wealth Management Group’s iShares US Medical Devices ETF IHI Stock Holding History

Strategic Wealth Management Group’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$215K	Buy	+3,570	New	+$206K	0.08%	120

Other funds holding IHI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Strategic Wealth Management Group's IHI Position: Q2 2021 in Review

Strategic Wealth Management Group opened a new position in iShares US Medical Devices ETF (IHI) in Q2 2021: 3,570 shares worth $215K. The stake represents 0.08% of the portfolio and ranks #120 among its holdings.

559 funds tracked by Wall St. Rank hold IHI as of Q2 2021.

Strategic Wealth Management Group held 3,570 shares of iShares US Medical Devices ETF worth $215K as of Q2 2021.
iShares US Medical Devices ETF was a new Strategic Wealth Management Group position in Q2 2021.
iShares US Medical Devices ETF made up 0.08% of Strategic Wealth Management Group's portfolio in Q2 2021, its #120 holding.
559 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2021.

Based on Strategic Wealth Management Group's 13F filing for Q2 2021, filed 13 Aug 2021.